Latest News

2 new influenza strains recommended for next season


 

REPORTING FROM AN FDA ADVISORY COMMITTEE MEETING

The CDC estimate of current vaccine effectiveness (VE) against influenza A (H3N2) viruses is 25%, as of Feb. 3. Effectiveness is even higher for all influenza viruses, with an estimated VE of 36%, indicating that the flu vaccine reduced a person’s risk of having to seek medical care at a doctor’s office for flu illness by 36% ( MMWR. 2018;67:180-5 ).

While the FDA usually follows the recommendations of its panel members, it is not obligated to do so. None of the committee members disclosed relevant financial conflicts of interest.

Pages

Recommended Reading

Influenza update: A robust season but there's (some) good news
MDedge Family Medicine
FDA warns against clarithromycin use in patients with heart disease
MDedge Family Medicine
Flu season shows signs of slowing
MDedge Family Medicine
Fluarix Quadrivalent effective in very young, simplifies flu shots for all ages
MDedge Family Medicine
HCV infection tied to premature ovarian senescence and a high miscarriage rate
MDedge Family Medicine
NASH rapidly overtaking hepatitis C as cause of liver cancer
MDedge Family Medicine
ACIP vaccine update
MDedge Family Medicine
VIDEO: The return of Kaposi’s sarcoma
MDedge Family Medicine
Preoperative penicillin allergy tests could decrease SSI
MDedge Family Medicine
Vaccines: Effectiveness vs. efficacy
MDedge Family Medicine